Becker's Healthcare April 16, 2024
Paige Twenter

Two in five accredited specialty pharmacies are owned by hospitals and other healthcare providers, but the nation’s three biggest pharmacy benefit managers accounted for 67% of specialty pharmacy revenue in 2023, according to Drug Channels.

Hospitals and health systems are the fastest-growing participants in this market, partly because of drugmakers’ restrictions regarding the 340B program, the report said.

The top 15 specialty pharmacies, according to 2023 revenue:

1. CVS Specialty (CVS Health) — $73.3 billion

2. Accredo/Freedom Fertility (Cigna/Evernorth/Express Scripts) — $59.5 billion

3. Other retail, mail, long-term care and specialty pharmacies — $37.4 billion

4. Optum Specialty...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
Project Optimus: helping or hindering cancer drug development?
Faster Drug Discovery: Yseop & AWS Unveils GenAI Tool for Biopharma R&D
Quest to ramp up AI capabilities with purchase of PathAI’s diagnostic lab
STAT+: Gilead gets a boost from California court in a case over slow-walking an HIV drug
Specialty Pharmacies Drive Cost Savings in Value-Based Care | Asembia 2024

Share This Article